Xenon Pharmaceuticals (XENE) Climbs 31.7% as Epilepsy Treatment Moves Forward
Xenon Pharmaceuticals climbed by 31.7 percent week-on-week, as investor sentiment was bolstered by positive clinical trial for its epilepsy and depression treatment candidate, alongside plans to submit...





